Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: Comparison of subcapsular and nonsubcapsular tumors

American Journal of Roentgenology

Volumn 186, Issue 5 SUPPL., 2006, Pages

  Yun, Ku Cho ^a   Rhim, Hyunchul ^b   Yong, Sik Ahn ^a   Mi, Young Kim ^a   Hyo, Keun Lim ^b  

^a Seoul Veterans Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Ablation; Liver disease; Radiofrequency

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; ELECTRODE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; ELECTRODES; EQUIPMENT DESIGN; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 33846295945     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.04.1346     Document Type: Article

References (28)

1. Lencioni R, Allgaier H, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228:235-240
2. Livraghi T, Goldberg S, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000; 214:761-768
3. Curley S, Izzo F, Ellis L, Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232:381-391
4. Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after radiofrequency ablation. Cancer 2003; 97:1253-1262
5. Hori T, Nagata K, Hasuike S, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003; 38:977-981
6. Bonny C, Abergel A, Gayard P, et al. Radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis [in French]. Gastroenterol Clin Biol 2002; 26:735-741
7. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumors. Br J Surg 2002; 89:1206-1222
8. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:1124-1129
9. Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR 2003; 181:695-700
10. Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 2004; 11:281-289
11. Pearson AS, Izzo F, Hemming D, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999; 178:592-598
12. Nguyen M, Garcia R, Simpson P, Wright T, Keeffe E. Racial differences in effectiveness of alpha-fetoprotein for the diagnosis of hepatocellular carcinoma in hepatitis C cirrhosis. Hepatology 2002; 36:410-417
13. Furuse J, Maru Y, Yoshino M, et al. Assessment of arterial tumor vascularity in small hepatocellular carcinoma: comparison between color Doppler ultrasonography and radiologic imaging with contrast medium: dynamic CT, angiography, and CT hepatic arteriography. Eur J Radiol 2000; 36:20-27
14. Lang E, Chen F, Fick L, Berbaum K. Determinants of intravenous conscious sedation for arteriography. J Vasc Interv Radiol 1998; 9:407-412
15. Kraft M, Arellano R, Mueller P. Conscious sedation for non-anesthesiologist: a primer. Semin Interv Radiol 1999; 16:89-98
16. Choi DI, Lim HK, Kim MJ, et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004; 230:135-141
17. Goldberg SN, Charboneau JW, Dodd GD, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335-345
18. Burke DR, Lewis CA, Cardella JF, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 1997; 18:677-681
19. Poon RT, Fan ST, Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232:10-24
20. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 1995; 2:670-674
21. Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3:212-218
22. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable radiofrequency needle electrode. AJR 1998; 170:1015-1022
23. Rossi S, Stasi M, Buscarini E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of hepatic cancer. AJR 1996; 167:759-768
24. Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR 2002; 178:53-59
25. Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow: comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2002; 95:2353-2360
26. Rhim H, Kim YS. Intrahepatic regional portal blood flow modulation using percutaneous US-monitoring portal vein compression during radiofrequency thermal ablation. Cardiovasc Intervent Radiol 2003; 26:416-418
27. Rhim H. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow: comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2003; 98:433-434
28. Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am 2003; 12:243-245